Filing metadata

Accession number
0001209191-22-035055
Form type
Form 4
Filer
Oyster Point Pharma, Inc.
CIK
CIK 1720725
Filed
Jun 08, 2022
Reporting period
Jun 06, 2022
Description
Insider transaction

Explore SEC Filings Hub